Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome

NCT01753674 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.

NCT NCT01753674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Lead sponsor
University of Connecticut
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2013
Completion date
June 30, 2014
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome